Johnson & Johnson named its consumer business Kenvue on Wednesday, moving ahead with its plans to spin-off the unit in what would be the biggest shake-up in the healthcare conglomerate’s 135-year history.
https://www.pharmalive.com/wp-content/uploads/2022/04/ReutersJnJ4182022.jpg485728Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-09-28 08:41:582022-09-28 10:24:26J&J names consumer health business Kenvue ahead of spin-off
